Chlamydia pneumoniae immunology

Chlamydiae are common pathogens that cause a number
of serious but preventable
diseases in both humans and animals. In the recent
years, Chlamydia pneumoniae has emerged as a major
cause of human respiratory disease and more
importantly, it has been linked to the establishment
and exacerbation of serious chronic diseases
including atherosclerosis and ischaemic heart
disease, multiple sclerosis and reactive arthritis.

There has been a lot of research into host responses
to chlamydial infections and the development of
immunopathology; but considerable gaps in our
knowledge remain. The work described here aimed to
analyse the early innate immune responses in the lung
following C. pneumoniae infections with a view to
better understanding host-pathogen interactions and
the role of the earliest immune responses in the
establishment of persistence and chronic inflammatory
disease.

Autorentext
Vjera Magdalenic conducted biomedical research over 5 years at
Kings College London and University of Edinburgh culminating in a
PhD in 2004. Vjera remains involved with biotechnology as Chief
Business Officer at LUX Innovate, Edinburgh, UK. Her work has
been presented and published academically and she co-authored
several patents at LUX Innovate.